Menopause epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The [[prevalence]] of [[menopause]] is estimated to be about | The [[prevalence]] of [[menopause]] is estimated to be about 50 million cases annually. [[Menopause]] naturally occurs in [[women]] between 49 to 52 of [[age]] the [[average]]. The [[Fatality rate|fatality]] cases were 345 cases per 3191 [[women]] aged between 50-86 years in the [[United States]]. There is no [[racial]] predilection to [[Menopause]], but African American [[women]] had experienced the largest number of [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] compared with other [[Ethnic group|ethnic groups]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
====Prevalence and Incidence==== | ====Prevalence and Incidence==== | ||
*In | * In 2001, the prevalence of menopause is estimated to be about 50 million cases worldwide will go into menopause annually. | ||
* | |||
*In 1990 there were 467 million postmenopausal women in the world, by 2030, [[menopausal]] [[women]] are projected to increase to 1.2 billion worldwide.<ref name="pmid8735350">{{cite journal| author=Hill K| title=The demography of menopause. | journal=Maturitas | year= 1996 | volume= 23 | issue= 2 | pages= 113-27 | pmid=8735350 | doi=10.1016/0378-5122(95)00968-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8735350 }} </ref> | |||
*The [[prevalence]] of [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] differ in [[women]] according to areas and countries that they live them, the [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] ranges from 74% of [[women]] in Europe, 36-50% in North America, 45-69% in [[Latin America]] and 22-63% in Asia.<ref name="pmid20690868">{{cite journal| author=Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P| title=Age of menopause and impact of climacteric symptoms by geographical region. | journal=Climacteric | year= 2010 | volume= 13 | issue= 5 | pages= 419-28 | pmid=20690868 | doi=10.3109/13697137.2010.507886 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20690868 }} </ref> | *The [[prevalence]] of [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] differ in [[women]] according to areas and countries that they live them, the [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] ranges from 74% of [[women]] in Europe, 36-50% in North America, 45-69% in [[Latin America]] and 22-63% in Asia.<ref name="pmid20690868">{{cite journal| author=Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P| title=Age of menopause and impact of climacteric symptoms by geographical region. | journal=Climacteric | year= 2010 | volume= 13 | issue= 5 | pages= 419-28 | pmid=20690868 | doi=10.3109/13697137.2010.507886 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20690868 }} </ref> | ||
*The [[prevalence]] of [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] among [[women]] prescribed [[hormone therapy]] ([[Hormonal therapy|HT]]), the mean age of patients was 54 years. The most common [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] were: [[hot flushes]] (40 %), [[night sweats]] (17 %), [[insomnia]] (16 %), [[vaginal dryness]] (13 %), [[mood disorders]] (12 %), and [[weight gain]] (12 %). | *The [[prevalence]] of [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] among [[women]] prescribed [[hormone therapy]] ([[Hormonal therapy|HT]]), the mean age of patients was 54 years. The most common [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptoms] were: [[hot flushes]] (40 %), [[night sweats]] (17 %), [[insomnia]] (16 %), [[vaginal dryness]] (13 %), [[mood disorders]] (12 %), and [[weight gain]] (12 %). | ||
*85 % of [[postmenopausal]] [[women]] have experienced a [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptom] in their lifetime, and the [[Prevalence]] of [https://www.contemporaryobgyn.net/view/managing-menopause-part-1-vasomotor-symptoms vasomotor symptoms]( [[hot flushes]] and/or [[night sweats]]) alone is estimated at approximately 40 to 50 million [[women]] in the [[United States]].<ref name="pmid26271251">{{cite journal| author=Sussman M, Trocio J, Best C, Mirkin S, Bushmakin AG, Yood R | display-authors=etal| title=Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records. | journal=BMC Womens Health | year= 2015 | volume= 15 | issue= | pages= 58 | pmid=26271251 | doi=10.1186/s12905-015-0217-y | pmc=4542113 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26271251 }} </ref> | *85 % of [[postmenopausal]] [[women]] have experienced a [https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397 menopausal symptom] in their lifetime, and the [[Prevalence]] of [https://www.contemporaryobgyn.net/view/managing-menopause-part-1-vasomotor-symptoms vasomotor symptoms]( [[hot flushes]] and/or [[night sweats]]) alone is estimated at approximately 40 to 50 million [[women]] in the [[United States]].<ref name="pmid26271251">{{cite journal| author=Sussman M, Trocio J, Best C, Mirkin S, Bushmakin AG, Yood R | display-authors=etal| title=Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records. | journal=BMC Womens Health | year= 2015 | volume= 15 | issue= | pages= 58 | pmid=26271251 | doi=10.1186/s12905-015-0217-y | pmc=4542113 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26271251 }} </ref> | ||
Revision as of 13:59, 10 February 2021
|
Menopause Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Menopause epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Menopause epidemiology and demographics |
|
Risk calculators and risk factors for Menopause epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Rahmah Al-Edresi, M.D.[2]
Overview
The prevalence of menopause is estimated to be about 50 million cases annually. Menopause naturally occurs in women between 49 to 52 of age the average. The fatality cases were 345 cases per 3191 women aged between 50-86 years in the United States. There is no racial predilection to Menopause, but African American women had experienced the largest number of menopausal symptoms compared with other ethnic groups.
Epidemiology and Demographics
Prevalence and Incidence
- In 2001, the prevalence of menopause is estimated to be about 50 million cases worldwide will go into menopause annually.
- In 1990 there were 467 million postmenopausal women in the world, by 2030, menopausal women are projected to increase to 1.2 billion worldwide.[1]
- The prevalence of menopausal symptoms differ in women according to areas and countries that they live them, the menopausal symptoms ranges from 74% of women in Europe, 36-50% in North America, 45-69% in Latin America and 22-63% in Asia.[2]
- The prevalence of menopausal symptoms among women prescribed hormone therapy (HT), the mean age of patients was 54 years. The most common menopausal symptoms were: hot flushes (40 %), night sweats (17 %), insomnia (16 %), vaginal dryness (13 %), mood disorders (12 %), and weight gain (12 %).
- 85 % of postmenopausal women have experienced a menopausal symptom in their lifetime, and the Prevalence of vasomotor symptoms( hot flushes and/or night sweats) alone is estimated at approximately 40 to 50 million women in the United States.[3]
Age
- The onset age of menopause between the ages of 50-53 in Europe.
- In North America, the onset age of menopause from 50-51years.
- In Latin America, the onset age of menopause from 44- 53 years.
- In Asia, the onset age of menopause from 42-49 years.[2]
Mortality rate
- In 1997, the fatality cases were 345 cases per 3191 women aged between 50-86 years in the United States over a mean follow-up time of 4.0 years.
- The mortality rate ratio (MRR) was 1.50% for women with menopause at age < 40, and the MRR of women with menopause at age 40-44 was 1.04%. While the MRR for women with menopause at age 45-49 was 0.96%.[4]
Race
- The prevalence of menopause does not vary by race.
- The ethnic differences in the symptoms experienced during the menopausal transition were noted. Asian women had experienced the smallest number of menopausal symptoms compared with all other ethnic groups, but African American women had experienced the largest number of menopausal symptoms compared with other ethnic groups.[5]
References
- ↑ Hill K (1996). "The demography of menopause". Maturitas. 23 (2): 113–27. doi:10.1016/0378-5122(95)00968-x. PMID 8735350.
- ↑ 2.0 2.1 Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P (2010). "Age of menopause and impact of climacteric symptoms by geographical region". Climacteric. 13 (5): 419–28. doi:10.3109/13697137.2010.507886. PMID 20690868.
- ↑ Sussman M, Trocio J, Best C, Mirkin S, Bushmakin AG, Yood R; et al. (2015). "Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records". BMC Womens Health. 15: 58. doi:10.1186/s12905-015-0217-y. PMC 4542113. PMID 26271251.
- ↑ Cooper GS, Sandler DP (1998). "Age at natural menopause and mortality". Ann Epidemiol. 8 (4): 229–35. doi:10.1016/s1047-2797(97)00207-x. PMID 9590601.
- ↑ Tsukamoto T, Sasaki H, Nakamura H (1989). "Treatment of hemoptysis patients by thrombin and fibrinogen-thrombin infusion therapy using a fiberoptic bronchoscope". Chest. 96 (3): 473–6. doi:10.1378/chest.96.3.473. PMID 2670463.